科研项目：
(1)国家自然科学基金委，地区基金，82060654，新型抗生素 zunyimycins 对阿尔茨海默病模型的保护作用及其机制研究，2021-01 至 2024-12，33 万。
(2)国家自然科学基金委，地区基金，81860653，整合素介导的蒽酮类抗生素 zunyimycin C 抗肝癌效应机制研究，2018-01 至 2022-12，32 万。
学术论文：
(近3年第一作者或通讯SCI/EI论文）
[1]Cheng J, Wu Q, Sun R, et al. Protective effects of a probiotic-fermented germinated grain complex on neurotransmitters and sleep quality in sleep-deprived mice. Front Microbiol. 2024;15:1438928.
[2]Gao Y, Li W, Huang X, Lyu Y, Yue C. Advances in Gut Microbiota-Targeted Therapeutics for Metabolic Syndrome. Microorganisms. 2024;12(5):851.
[3]Tan C, Wang N, Deng S, et al. The development and application of pseudoviruses: assessment of SARS-CoV-2 pseudoviruses. PeerJ. 2023;11:e16234.
[4]Zhang Y, Wang X, Li W, et al. Intestinal microbiota: a new perspective on delaying aging?. Front Microbiol. 2023;14:1268142.
[5]Hu Y, Zhao Y, Jia X, et al. Lactic acid bacteria with a strong antioxidant function isolated from "Jiangshui," pickles, and feces. Front Microbiol. 2023;14:1163662.
[6]Zhu X, Guo R, Su X, et al. Immune-enhancing activity of polysaccharides and flavonoids derived from Phellinus igniarius YASH1. Front Pharmacol. 2023;14:1124607.
[7]Huang X, Yang Y, Li X, et al. The gut microbiota: A new perspective for tertiary prevention of hepatobiliary and gallbladder diseases. Front Nutr. 2023;10:1089909.
[8]Hu Y, Zhang X, Deng S, Yue C, Jia X, Lyu Y. Non-antibiotic prevention and treatment against Acinetobacter baumannii infection: Are vaccines and adjuvants effective strategies?. Front Microbiol. 2023;14:1049917.
[9]Wang X, Li Z, Sun R, et al. Zunyimycin C enhances immunity and improves cognitive impairment and its mechanism. Front Cell Infect Microbiol. 2022;12:1081243
[10]Cui X, Wang L, Lü Y, Yue C. Development and research progress of anti-drug resistant fungal drugs. J Infect Public Health. 2022;15(9):986-1000.
Liu P, Yue C, Liu L, et al. The function of small RNA in Pseudomonas aeruginosa. PeerJ. 2022;10:e13738.
[11]Ma J, Lyu Y, Liu X, et al. Correction to: Engineered probiotics. Microb Cell Fact. 2022;21(1):93.
[12]Lü YH,Wang YQ,Li XQ,Cui XY, Liu T, Tian P, Zhang ZM, Yue CW. Antibacterial activity of Zunyimycin C against methicillin resistant Staphylococcus aureus clinical isolates, Journal of Biotech Research, 2020, 11: 179-186. EI
[13]Lü YH, Cui XY, Yue CW. Molecular diagnosis and drug development in both Alzheimer's and Parkinson's diseases, Journal of Biotech Research, 2020, 11: 141-154. EI
[14]Wang XM, Li XL, Zhang Lin, Guo RR, Sun XY, Sun R, Li ZX, Wang, LL, Yue CW, Lyu YH. Emerging evolution trends of application of natural products in Alzheimer’s disease. Journal of Computational Methods in Sciences and Engineering.2022,22(2):649-659.
[15]Wang M, Li XL, Wang XM, Guo RR, Sun XY, Sun R, Li ZX, Wang LL, Yue CW , Lü YH. Heterologous expression of abx gene cluster in E. coli gives production of 2-heptyl-4(1H)- quinolone. Journal of Biotech Research.2021, 12:152-160
专 利：（近3年授权第一发明人国家发明专利）
[1]吕玉红,李晓倩,岳昌武等. 卤化Ⅱ型聚酮类抗生素在抑制黑色素瘤细胞增殖中的应用[P]. 陕西省：CN109966287B,2022-04-15.
[2]吕玉红,李晓倩,岳昌武等. 卤化Ⅱ型聚酮类抗生素在抑制乳腺癌细胞增殖中的应用[P]. 陕西省：CN109999023B,2022-02-22. |
